ProMIS

This person does not yet have a bio.

Content by ProMIS

| 5 min read

Guest Commentary: Targeting α-synuclein and the pathogenesis of Parkinson’s disease

Discovery of antibodies highly selective for toxic α-synuclein conformations may require more than just classical methods if pharma and life sciences want to make faster progress against Parkinson's disease

Articles

Page 1 of 1 - 1 Total Items

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.

Advancing predictive in vitro models

Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.

Webinars